CTKB logo

CTKB Cytek Biosciences, Inc.

NASDAQ Global Select · Medical - Devices · Healthcare

$6.12
-0.20 (-3.16%)

Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to different…

Market Cap: $800.40Mcytekbio.com

Price

No data yet.

Social Signal Score

43
5d
50
1 mentions
—
30d
38
5 mentions
—
60d
40
6 mentions
—
90d
45
12 mentions
—
news: 12

Analyst Ratings

5 analysts
Buyconsensus
Strong Buy 0Buy 3Hold 1Sell 1Strong Sell 0
Avg price target$5.5-10.1%
Low $5Median $5.5High $6
Current Consensus

Revenue

$53.23M+195.91%
$17.99M$32.71M$47.42M$62.14M
Mar 2020Sep 2026

Analyst Estimates

FY2025
$-0.13
$-0.26–$0.06
2 analysts
FY2026
$-0.29
$-0.29–$-0.28
2 analysts
FY2027
$-0.18
$-0.18–$-0.18
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Wenbin Jiang
Sector
Healthcare
Industry
Medical - Devices
Employees
703
Beta
1.14
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
4.38
cytekbio.com